bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2013: M A M F J
2012: D N O S A J J M

 
  Other news for:
Physicians
Epilepsy
 Resources from HONselect
People May Skip Generic Pills if Color Differs From Brand-Name Drug
Study found patients on anti-seizure meds were less likely to refill such prescriptions

By Robert Preidt

WEDNESDAY, Jan. 2 (HealthDay News) -- Differences in the color of generic drugs increase the risk that patients will stop taking their medication, which can have potentially serious consequences, a new study indicates.

Generic drugs, which account for more than 70 percent of prescriptions, provide the same health benefits as brand-name drugs but often vary in color and shape.

In this study, researchers at Brigham and Women's Hospital in Boston analyzed national data on patients taking anti-epileptic drugs and found that patients were over 50 percent more likely to stop taking their medication as prescribed if they received pills that were a different color than pills they had previously taken.

This was determined from the longer time lapses in having such prescriptions refilled.

The shape of the pills did not have an effect, according to the study published online Dec. 31 in the journal Archives of Internal Medicine.

Patients who stop taking anti-epileptic drugs for even a few days are at increased risk of seizure and could experience health and social consequences, the researchers pointed out in a hospital news release.

"Pill appearance has long been suspected to be linked to medication adherence, yet this is the first empirical analysis that we know of that directly links pills' physical characteristics to patients' adherence behavior," study principal investigator Dr. Aaron Kesselheim, an assistant professor of medicine in the division of pharmacoepidemiology and pharmacoeconomics, said in the news release.

"Patients should be aware that their pills may change color and shape, but that even differently appearing generic drugs are approved by the [U.S. Food and Drug Administration] as being bioequivalent to their brand-name counterparts and are safe to take," Kesselheim said.

"Physicians should be aware that changes in pill appearance might explain their patients' non-adherence. Finally, pharmacists should make a point to tell patients about the change in color and shape when they change generic suppliers," he added.

Many factors affect whether patients take their medications, but allowing or requiring brand-name and generic pills to look the same may be a simple way to improve medication adherence, the researchers suggested.

More information

The U.S. Food and Drug Administration has more about medication adherence.

SOURCE: Brigham and Women's Hospital, news release, Dec. 31, 2012

Copyright © 2012 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=671812

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Specialty Chemicals and Products
Research Personnel
Risk
Physicians
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact